Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04227535

Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
509 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The overall goal of this study is to identify risk and prognosis factors of Interstitial Lung Disease (ILD) in patients with rheumatoid arthritis (RA).

Detailed description

This is not an interventional study. This is a study designed to recruit individuals affected by RA and investigate associated ILD to better understand the clinical phenotypes and genetic/molecular endotypes of RAILD, including the prognosis of the disease.

Conditions

Timeline

Start date
2020-02-03
Primary completion
2027-10-01
Completion
2027-10-01
First posted
2020-01-13
Last updated
2023-04-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04227535. Inclusion in this directory is not an endorsement.

Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2 (NCT04227535) · Clinical Trials Directory